These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 35224730)

  • 21. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone antagonists for people with chronic kidney disease requiring dialysis.
    Hasegawa T; Nishiwaki H; Ota E; Levack WM; Noma H
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013109. PubMed ID: 33586138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease.
    Natale P; Palmer SC; Jaure A; Hodson EM; Ruospo M; Cooper TE; Hahn D; Saglimbene VM; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013751. PubMed ID: 36005278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
    Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
    Hara T; Hijikata Y; Matsubara Y; Watanabe N
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.
    Htay H; Johnson DW; Craig JC; Teixeira-Pinto A; Hawley CM; Cho Y
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012899. PubMed ID: 33501650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Education programmes for people with chronic kidney disease and diabetes.
    Cashmore BA; Cooper TE; Evangelidis NM; Green SC; Lopez-Vargas P; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD007374. PubMed ID: 39171639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin for preventing the progression of chronic kidney disease.
    El-Damanawi R; Stanley IK; Staatz C; Pascoe EM; Craig JC; Johnson DW; Mallett AJ; Hawley CM; Milanzi E; Hiemstra TF; Viecelli AK
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013414. PubMed ID: 38837240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-immunosuppressive treatment for IgA nephropathy.
    Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
    Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions for dialysis patients with hepatitis C virus (HCV) infection.
    Prabhu AR; Rao IR; Nagaraju SP; Rajwar E; Venkatesh BT; Nair N S; Pai G; Reddy NP; Suvarna D
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007003. PubMed ID: 37096802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
    Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012467. PubMed ID: 33314078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012467. PubMed ID: 32164041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose targets for preventing diabetic kidney disease and its progression.
    Ruospo M; Saglimbene VM; Palmer SC; De Cosmo S; Pacilli A; Lamacchia O; Cignarelli M; Fioretto P; Vecchio M; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010137. PubMed ID: 28594069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parenteral versus oral iron therapy for adults and children with chronic kidney disease.
    O'Lone EL; Hodson EM; Nistor I; Bolignano D; Webster AC; Craig JC
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD007857. PubMed ID: 30790278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for preventing and treating kidney disease in IgA vasculitis.
    Hahn D; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD005128. PubMed ID: 36853224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis.
    Mah JY; Choy SW; Roberts MA; Desai AM; Corken M; Gwini SM; McMahon LP
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012616. PubMed ID: 32390133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.